What is DuPont de Nemours, Inc.'s earnings per share (EPS)?

DuPont de Nemours, Inc. (DD) reported diluted earnings per share of -$1.86 for fiscal year 2025. This represents a -210.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

DuPont de Nemours, Inc. (DD) Financials

Trailing 12 months to June 30, 2026

Revenue $7.0B +3.3% YoY

Net Income $55.0M +128.5% YoY

EPS (Diluted) -$1.86 FY2025 annual

Free Cash Flow $402.0M +192.6% YoY

Market Cap $17.6B as of Oct 6, 2026

Price / Sales 2.5x on $7.0B revenue, trailing 12 months to June 30, 2026

Price / Earnings 321x on $55.0M net income, trailing 12 months to June 30, 2026

Price / Book 1.3x on $13.8B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DD SEC filings page.

DuPont de Nemours, Inc. (DD) reported $7.0B in revenue over the twelve months to Jun 30, 2026, up 3.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DD FY2025 2026-10-04

Revenue has stabilized after a major asset-base contraction, but thin net earnings and dividends now exceed retained cash generation.

Across FY2023-FY2025, gross margin widened by 1.7 percentage points even as net margin fell to 1.3%, showing that the recent earnings pressure sits below product-level profitability rather than in gross economics. FY2025 operating cash flow of $560M exceeded net income of $88M, but free cash flow was only $227M, indicating that non-cash charges and reinvestment materially shape reported earnings conversion.

Total assets fell from $36.6B to $21.6B between FY2024 and FY2025 while revenue remained broadly stable, implying a much smaller operating balance sheet rather than a sales-led contraction. Debt-to-equity declined from 0.3x to 0.2x, so the asset reset also left the company less debt-dependent.

Cash generation remains positive but is not covering distributions after reinvestment: FY2025 free cash flow of $227M was below dividends paid of $597M. The combination of positive operating cash flow and low net income also means the income statement understates the cash produced by the continuing operation, while capital spending still absorbs a meaningful share of it.

Financial Health Signals

Financial Health Score 38/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of DuPont de Nemours, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for DuPont de Nemours, Inc., and counted as zero in the overall score.

Growth

DuPont de Nemours, Inc.'s revenue grew a modest 1.9% year-over-year to $6.8B. This slow but positive growth earns a score of 37/100.

Leverage

DuPont de Nemours, Inc. carries a low D/E ratio of 0.23, meaning only $0.23 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 74/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 2.42, DuPont de Nemours, Inc. holds $2.42 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 69/100.

Cash Flow

DuPont de Nemours, Inc. has a free cash flow margin of 3.3%, earning a moderate score of 47/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Not available for DuPont de Nemours, Inc., and counted as zero in the overall score.

Piotroski F-Score Strong

7/9

DuPont de Nemours, Inc. passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

6.36x

For every $1 of reported earnings, DuPont de Nemours, Inc. generates $6.36 in operating cash flow ($560.0M OCF vs $88.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.8B

YoY+4.0%

QoQ+8.2%

DuPont de Nemours, Inc. generated $1.8B in revenue in Q2 2026. This represents an increase of 4.0% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.

Net Income

$143.0M

YoY+142.4%

QoQ-11.2%

DuPont de Nemours, Inc. reported $143.0M in net income in Q2 2026. This represents an increase of 142.4% from the same quarter a year earlier. Against the prior quarter it is down 11.2%.

EPS (Diluted)

$1.05

5Y CAGR+3.1%

10Y CAGR-8.7%

DuPont de Nemours, Inc. earned $1.05 per diluted share (EPS) in Q2 2026.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$324.0M

YoY+1250.0%

QoQ+149.2%

5Y CAGR+7.7%

DuPont de Nemours, Inc. generated $324.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 1250.0% from the same quarter a year earlier. Against the prior quarter it is up 149.2%.

Cash & Debt

$1.7B

YoY-5.3%

QoQ+145.1%

5Y CAGR-15.2%

DuPont de Nemours, Inc. held $1.7B in cash against $3.1B in long-term debt as of Q2 2026.

Dividends Per Share

$0.60

DuPont de Nemours, Inc. paid $0.60 per share in dividends in Q2 2026.

Shares Outstanding

135M

5Y CAGR-23.7%

DuPont de Nemours, Inc. had 135M shares outstanding in Q2 2026.

Margins & Returns

Gross Margin

35.1%

YoY+0.5pp

QoQ-0.7pp

DuPont de Nemours, Inc.'s gross margin was 35.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Net Margin

7.9%

YoY+4.5pp

QoQ-1.7pp

DuPont de Nemours, Inc.'s net profit margin was 7.9% in Q2 2026, showing the share of revenue converted to profit. This is up 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.7 percentage points.

Return on Equity

1.0%

YoY+0.8pp

QoQ-0.1pp

DuPont de Nemours, Inc.'s ROE was 1.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$42.0M

YoY-20.8%

QoQ-10.6%

DuPont de Nemours, Inc. invested $42.0M in research and development in Q2 2026. This represents a decrease of 20.8% from the same quarter a year earlier. Against the prior quarter it is down 10.6%.

Capital Expenditures

$76.0M

YoY+52.0%

QoQ-25.5%

5Y CAGR-18.9%

DuPont de Nemours, Inc. invested $76.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 52.0% from the same quarter a year earlier. Against the prior quarter it is down 25.5%.

Share Buybacks

Not reported for Q2 2026.

DD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DD quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Revenue	$7.0B	$6.8B+1.9%	$6.7B+1.6%	$6.6B-49.2%	$13.0B+3.6%	$12.6B-12.4%	$14.3B-7.1%	$15.4B-5.8%	$16.4B+40.3%	$11.7B-75.8%	$48.2B-1.3%	$48.8B
Cost of Revenue	$4.5B	$4.5B-0.3%	$4.5B+1.3%	$4.4B-47.1%	$8.4B+5.4%	$8.0B+12.9%	$7.1B-29.6%	$10.0B-9.9%	$11.1B+16.4%	$9.6B-74.6%	$37.7B-0.2%	$37.7B
Gross Profit	$2.5B	$2.4B+6.4%	$2.2B+2.2%	$2.2B-52.9%	$4.6B+0.4%	$4.6B-36.8%	$7.3B+34.5%	$5.4B+2.9%	$5.3B+148.6%	$2.1B-79.9%	$10.5B-4.7%	$11.0B
R&D Expenses	N/A	$193.0M-4.9%	$203.0M+5.7%	$192.0M-64.2%	$536.0M-3.8%	$557.0M-1.4%	$565.0M-18.0%	$689.0M-13.6%	$797.0M+21.3%	$657.0M-58.8%	$1.6B-0.3%	$1.6B
SG&A Expenses	N/A	$1.0B+4.4%	$976.0M+9.5%	$891.0M-39.3%	$1.5B-8.4%	$1.6B+7.4%	$1.5B-27.5%	$2.1B-14.4%	$2.4B+48.8%	$1.6B-45.3%	$3.0B+0.2%	$2.9B
Interest Expense	N/A	$313.0M-14.5%	$366.0M-7.6%	$396.0M-19.5%	$492.0M-6.3%	$525.0M-21.9%	$672.0M+0.7%	$667.0M+1135.2%	$54.0M	$0-100.0%	$858.0M-9.3%	$946.0M
Income Tax	N/A	$102.0M-52.1%	$213.0M+198.2%	-$217.0M-156.1%	$387.0M+63.3%	$237.0M+163.3%	$90.0M+4600.0%	-$2.0M-104.0%	$50.0M+102.8%	-$1.8B-19633.3%	$9.0M-99.6%	$2.1B
Net Income	$55.0M	$88.0M-87.5%	$703.0M+66.2%	$423.0M-92.8%	$5.9B-9.3%	$6.5B+319.1%	-$3.0B-692.6%	$498.0M-87.0%	$3.8B+231.8%	$1.2B-73.2%	$4.3B-43.8%	$7.7B
EPS (Basic)	N/A	-$1.87-211.3%	$1.68+78.7%	$0.94-92.0%	$11.77-1.3%	$11.92+397.3%	-$4.01-698.5%	$0.67-86.6%	$4.99+128.9%	$2.18-38.9%	$3.57-44.7%	$6.45
EPS (Diluted)	—	-$1.86-210.7%	$1.68+78.7%	$0.94-92.0%	$11.75-1.2%	$11.89+396.5%	-$4.01-698.5%	$0.67	$4.99+132.1%	$2.15	$3.52-42.8%	$6.15
Diluted Shares (Avg)	N/A	419M0.0%	419M-6.8%	450M-9.9%	499M-8.2%	544M-26.0%	736M-1.4%	746M	767M+44.0%	533M	1.12B-9.5%	1.24B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$1.8B+4.0%	$1.7B+4.3%	$1.7B+0.2%	$1.8B+4.7%	$1.7B+1.9%	$1.6B+0.8%	$1.7B	$1.7B-44.0%
Cost of Revenue	$1.2B+3.2%	$1.1B+0.9%	$1.1B-3.6%	$1.2B+4.0%	$1.1B+1.1%	$1.1B-2.6%	$1.1B	$1.1B-42.0%
Gross Profit	$639.0M+5.4%	$602.0M+10.9%	$598.0M+8.1%	$616.0M+6.2%	$606.0M+3.4%	$543.0M+8.4%	$553.0M	$580.0M-47.5%
R&D Expenses	$42.0M-20.8%	$47.0M-6.0%	N/A	$140.0M+10.2%	$53.0M-60.4%	$50.0M-60.0%	N/A	$127.0M-0.8%
SG&A Expenses	$269.0M+2.7%	$255.0M+9.0%	N/A	$387.0M+5.2%	$262.0M-37.3%	$234.0M-39.1%	N/A	$368.0M+2.2%
Interest Expense	$41.0M-51.2%	$40.0M-51.8%	N/A	$99.0M+13.8%	$84.0M-15.2%	$83.0M-13.5%	N/A	$87.0M-14.7%
Income Tax	$75.0M+38.9%	$31.0M+82.4%	N/A	$19.0M-80.8%	$54.0M-55.0%	$17.0M-79.8%	N/A	$99.0M-15.4%
Net Income	$143.0M+142.4%	$161.0M+127.3%	-$126.0M-7.7%	-$123.0M-127.1%	$59.0M-66.9%	-$589.0M-413.3%	-$117.0M	$454.0M+42.3%
EPS (Basic)	$1.05+150.0%	$0.39+127.7%	-$0.30-7.1%	-$0.29-126.6%	$0.42-2.3%	-$1.41-420.5%	-$0.28-833.3%	$1.09+53.5%
EPS (Diluted)	$1.05	$0.39+127.9%	-$0.30-7.1%	-$0.29-126.9%	$0.42	-$1.40-418.2%	-$0.28-833.3%	$1.08+54.3%
Diluted Shares (Avg)	137M	413M-1.7%	N/A	420M+0.1%	140M	420M-1.0%	N/A	420M-7.5%

Not reported in any period shown, so not listed: Operating Income, EBITDA.

DD Balance Sheet

DD quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Total Assets	$21.6B-41.1%	$36.6B-5.0%	$38.6B-6.8%	$41.4B-9.5%	$45.7B-35.5%	$70.9B+2.2%	$69.3B-63.1%	$187.9B-2.1%	$191.9B+141.4%	$79.5B+17.0%	$67.9B
Current Assets	$5.6B-73.2%	$20.8B+176.5%	$7.5B-33.3%	$11.3B-21.2%	$14.3B-50.7%	$29.0B+190.1%	$10.0B-92.1%	$126.7B+153.9%	$49.9B+110.9%	$23.7B	N/A
Cash & Equivalents	$715.0M-60.1%	$1.8B-25.1%	$2.4B-34.7%	$3.7B+85.7%	$2.0B-22.5%	$2.5B+65.2%	$1.5B-82.0%	$8.5B-36.4%	$13.4B+103.4%	$6.6B-23.0%	$8.6B
Short-Term Investments	$0	$0	$0-100.0%	$1.3B	$0	$0	$0-100.0%	$29.0M-97.0%	$956.0M	$0	$0
Inventory	$1.2B+3.7%	$1.1B-47.4%	$2.1B-7.8%	$2.3B+11.6%	$2.1B-12.8%	$2.4B-17.4%	$2.9B-29.5%	$4.1B-75.8%	$17.0B+130.8%	$7.4B	N/A
Accounts Receivable	$910.0M+15.3%	$789.0M-47.9%	$1.5B-3.4%	$1.6B-2.8%	$1.6B-12.9%	$1.9B-9.6%	$2.0B-29.2%	$2.9B-74.4%	$11.3B+142.5%	$4.7B	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0-100.0%	$24.0M-98.6%	$1.7B+22.7%	$1.4B+9.5%	$1.3B	$0
Goodwill	$7.9B+4.7%	$7.6B-1.3%	$7.7B-54.0%	$16.7B-1.9%	$17.0B+5.9%	$16.0B-27.5%	$22.1B-1.1%	$22.4B-35.7%	$34.8B+128.0%	$15.3B+25.7%	$12.2B
Total Liabilities	$7.5B-41.8%	$12.8B-7.1%	$13.8B-3.6%	$14.3B-23.1%	$18.7B-41.4%	$31.8B+14.5%	$27.8B-69.8%	$92.0B+0.4%	$91.6B+71.1%	$53.5B+28.2%	$41.8B
Current Liabilities	$2.3B-58.1%	$5.5B+77.4%	$3.1B-17.0%	$3.7B-24.3%	$4.9B-59.7%	$12.2B+46.5%	$8.3B-88.6%	$73.3B+180.6%	$26.1B+107.3%	$12.6B	N/A
Non-Current Liabilities	$5.2B-29.7%	$7.3B-31.5%	$10.7B+1.2%	$10.6B-22.7%	$13.7B-30.0%	$19.6B+0.8%	$19.4B+4.3%	$18.6B-71.5%	$65.4B+59.9%	$40.9B	N/A
Long-Term Debt	$3.1B-41.1%	$5.3B-31.8%	$7.8B+0.3%	$7.8B-26.9%	$10.6B-31.9%	$15.6B+14.7%	$13.6B+7.8%	$12.6B-58.0%	$30.1B+46.9%	$20.5B	N/A
Total Equity	$13.9B-40.4%	$23.4B-3.8%	$24.3B-8.6%	$26.6B+0.5%	$26.4B-31.3%	$38.5B-6.1%	$41.0B-56.5%	$94.3B-6.0%	$100.3B+286.1%	$26.0B-0.7%	$26.2B
Retained Earnings	-$24.3B-5.2%	-$23.1B-0.9%	-$22.9B-8.6%	-$21.1B+9.2%	-$23.2B-100.1%	-$11.6B-37.9%	-$8.4B-127.8%	$30.3B+3.6%	$29.2B-3.7%	$30.3B	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$21.1B-42.4%	$21.4B-40.4%	$21.6B-41.1%	$38.0B+1.6%	$36.6B0.0%	$36.0B-4.6%	$36.6B-5.0%	$37.5B-4.3%
Current Assets	$4.9B-29.1%	$5.6B-12.7%	$5.6B-73.2%	$10.0B+55.6%	$6.8B+11.1%	$6.5B-8.5%	$20.8B+176.5%	$6.4B-18.9%
Cash & Equivalents	$1.7B-5.3%	$710.0M-59.7%	$715.0M-60.1%	$2.0B+18.8%	$1.8B+22.2%	$1.8B-8.9%	$1.8B-25.1%	$1.6B+22.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.2B-47.3%	$1.2B-46.1%	$1.2B+3.7%	$1.8B-17.8%	$2.3B+6.1%	$2.2B+3.1%	$1.1B-47.4%	$2.2B-1.8%
Accounts Receivable	N/A	N/A	$910.0M+15.3%	N/A	N/A	N/A	$789.0M-47.9%	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$7.8B-51.7%	$7.9B-50.7%	$7.9B+4.7%	$16.2B-3.8%	$16.2B-1.9%	$15.9B-4.0%	$7.6B-1.3%	$16.9B-2.2%
Total Liabilities	$7.2B-45.0%	$7.2B-43.3%	$7.5B-41.8%	$14.7B+14.8%	$13.0B+2.0%	$12.7B-7.2%	$12.8B-7.1%	$12.8B-11.7%
Current Liabilities	$2.0B-58.8%	$2.1B-54.6%	$2.3B-58.1%	$5.0B+77.2%	$4.9B+74.2%	$4.6B+52.8%	$5.5B+77.4%	$2.8B-23.4%
Non-Current Liabilities	$5.2B-36.8%	$5.1B-36.8%	$5.2B-29.7%	$9.7B-2.8%	$8.2B-18.1%	$8.1B-24.3%	$7.3B-31.5%	$10.0B-7.8%
Long-Term Debt	$3.1B-41.3%	$3.1B-41.2%	$3.1B-41.1%	$7.0B-1.7%	$5.3B-25.7%	$5.3B-31.5%	$5.3B-31.8%	$7.2B-7.4%
Total Equity	$13.8B-40.3%	$14.0B-38.5%	$13.9B-40.4%	$22.9B-5.4%	$23.1B-1.2%	$22.8B-3.2%	$23.4B-3.8%	$24.2B+0.1%
Retained Earnings	-$24.3B-3.1%	-$24.2B-2.3%	-$24.3B-5.2%	-$23.7B-3.3%	-$23.6B-0.8%	-$23.7B-0.6%	-$23.1B-0.9%	-$23.0B-0.5%

DD Cash Flow Statement

DD quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Operating Cash Flow	$1.0B	$560.0M-26.8%	$765.0M-9.5%	$845.0M+43.7%	$588.0M-74.2%	$2.3B-44.3%	$4.1B+190.6%	$1.4B-70.2%	$4.7B+718.4%	-$765.0M+74.1%	-$3.0B-138.9%	$7.6B
Depreciation & Amortization	N/A	$647.0M+1.9%	$635.0M+9.5%	$580.0M-48.9%	$1.1B+2.1%	$1.1B-64.1%	$3.1B-3.2%	$3.2B+107.6%	$1.5B+45.2%	$1.1B-63.0%	$2.9B+13.5%	$2.5B
Stock-Based Compensation	N/A	$38.0M-32.1%	$56.0M-1.8%	$57.0M-24.0%	$75.0M+11.9%	$67.0M-28.0%	$93.0M+6.9%	$87.0M+19.2%	$73.0M+284.2%	$19.0M-92.7%	$261.0M-25.9%	$352.0M
Capital Expenditures	$339.0M	$333.0M+16.8%	$285.0M-5.6%	$302.0M-54.4%	$662.0M-16.0%	$788.0M-34.0%	$1.2B-51.7%	$2.5B+98.7%	$1.2B+125.8%	$551.0M-85.5%	$3.8B+2.7%	$3.7B
Free Cash Flow	$402.0M	$227.0M-52.7%	$480.0M-11.6%	$543.0M+833.8%	-$74.0M-105.0%	$1.5B-48.5%	$2.9B+372.9%	-$1.1B-130.5%	$3.5B+365.0%	-$1.3B+80.5%	-$6.8B-273.2%	$3.9B
Investing Cash Flow	N/A	N/A	N/A	N/A	$8.9B+471.6%	-$2.4B-1088.6%	-$202.0M+91.3%	-$2.3B+6.1%	-$2.5B-117.2%	$14.3B+181.3%	$5.1B+477.2%	-$1.4B
Financing Cash Flow	N/A	N/A	N/A	N/A	-$7.7B-17.8%	-$6.5B-301.0%	$3.2B+128.0%	-$11.6B-502.2%	-$1.9B+70.7%	-$6.6B-63.3%	-$4.0B-28.2%	-$3.1B
Dividends Paid	$417.0M	$597.0M-6.0%	$635.0M-2.5%	$651.0M-0.2%	$652.0M+3.5%	$630.0M-28.6%	$882.0M-45.3%	$1.6B-53.9%	$3.5B+2.9%	$3.4B+37.9%	$2.5B+9.3%	$2.3B
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$2.1B+823.7%	$232.0M-90.0%	$2.3B-47.3%	$4.4B+342.1%	$1.0B+9.2%	$916.0M-21.4%	$1.2B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$400.0M+440.5%	$232.0M+201.3%	-$700.0M+6.9%	$1.1B+123.1%	$74.0M-86.0%	$77.0M-84.4%	-$752.0M-7.4%	$497.0M-32.8%
Depreciation & Amortization	$154.0M-7.2%	$155.0M-3.1%	-$125.0M+12.0%	$257.0M-3.7%	$166.0M-44.3%	$160.0M-45.0%	-$142.0M+48.0%	$267.0M-9.2%
Stock-Based Compensation	$14.0M-6.7%	$13.0M+85.7%	N/A	$13.0M-23.5%	$15.0M-25.0%	$7.0M-69.6%	N/A	$17.0M-22.7%
Capital Expenditures	$76.0M+52.0%	$102.0M-16.4%	-$150.0M+64.8%	$311.0M+364.2%	$50.0M-51.0%	$122.0M-41.1%	-$91.0M-47.1%	$67.0M-43.7%
Free Cash Flow	$324.0M+1250.0%	$130.0M+388.9%	-$850.0M-0.8%	$798.0M+85.6%	$24.0M-94.4%	-$45.0M-115.7%	-$843.0M+3.3%	$430.0M-30.8%
Investing Cash Flow	N/A	N/A	N/A	N/A	-$111.0M-11.0%	-$247.0M-22.3%	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	-$184.0M+78.1%	-$206.0M+70.2%	N/A	-$140.0M+92.9%
Dividends Paid	$81.0M-52.6%	$82.0M-52.3%	$82.0M-48.4%	$172.0M+8.2%	$171.0M+8.2%	$172.0M+8.2%	$159.0M+1.9%	$159.0M-3.6%

Not reported in any period shown, so not listed: Share Buybacks.

DD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DD quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Gross Margin	34.5%+1.5pp	33.0%+0.2pp	32.8%-2.6pp	35.4%-1.1pp	36.6%-14.2pp	50.7%+15.7pp	35.0%+3.0pp	32.1%+14.0pp	18.1%-3.7pp	21.8%-0.8pp	22.6%
Net Margin	1.3%-9.2pp	10.5%+4.1pp	6.4%-38.7pp	45.1%-6.4pp	51.5%+72.0pp	-20.6%-23.8pp	3.2%-20.3pp	23.5%+13.6pp	9.9%+1.0pp	9.0%-6.8pp	15.8%
Return on Equity	0.6%-2.4pp	3.0%+1.3pp	1.7%-20.4pp	22.1%-2.4pp	24.5%+32.1pp	-7.7%-8.9pp	1.2%-2.9pp	4.1%+2.9pp	1.2%-15.5pp	16.6%-12.7pp	29.3%
Return on Assets	0.4%-1.5pp	1.9%+0.8pp	1.1%-13.1pp	14.2%0.0pp	14.1%+18.3pp	-4.2%-4.9pp	0.7%-1.3pp	2.1%+1.5pp	0.6%-4.8pp	5.4%-5.9pp	11.3%
Current Ratio	2.42-1.4x	3.78+1.4x	2.43-0.6x	3.02+0.1x	2.90+0.5x	2.37+1.2x	1.20-0.5x	1.73-0.2x	1.910.0x	1.88	N/A
Debt-to-Equity	0.230.0x	0.23-0.1x	0.320.0x	0.29-0.1x	0.400.0x	0.41+0.1x	0.33+0.2x	0.13-0.2x	0.30-0.5x	0.79-0.8x	1.59
Asset Turnover	0.32+0.1x	0.180.0x	0.17-0.1x	0.310.0x	0.27+0.1x	0.200.0x	0.22+0.1x	0.090.0x	0.06-0.5x	0.61-0.1x	0.72
FCF Margin	3.3%-3.8pp	7.1%-1.1pp	8.2%+8.8pp	-0.6%-12.4pp	11.9%-8.3pp	20.2%+27.1pp	-6.9%-28.2pp	21.3%+32.6pp	-11.3%+2.8pp	-14.0%-22.0pp	8.0%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Gross Margin	35.1%+0.5pp	35.8%+2.1pp	35.3%+2.6pp	34.3%+0.5pp	34.6%+0.5pp	33.7%+2.3pp	32.7%	33.8%-2.3pp
Net Margin	7.9%+4.5pp	9.6%+46.1pp	-7.4%-0.5pp	-6.9%-33.3pp	3.4%-7.0pp	-36.5%-48.3pp	-6.9%	26.5%+16.1pp
Return on Equity	1.0%+0.8pp	1.1%+3.7pp	-0.9%-0.4pp	-0.5%-2.4pp	0.3%-0.5pp	-2.6%-3.4pp	-0.5%	1.9%+0.6pp
Return on Assets	0.7%+0.5pp	0.8%+2.4pp	-0.6%-0.3pp	-0.3%-1.5pp	0.2%-0.3pp	-1.6%-2.1pp	-0.3%	1.2%+0.4pp
Current Ratio	2.43+1.0x	2.68+1.3x	2.42-1.4x	2.00-0.3x	1.41-0.8x	1.40-0.9x	3.78+1.4x	2.28+0.1x
Debt-to-Equity	0.230.0x	0.220.0x	0.230.0x	0.310.0x	0.23-0.1x	0.23-0.1x	0.23-0.1x	0.300.0x
Asset Turnover	0.090.0x	0.080.0x	0.080.0x	0.050.0x	0.050.0x	0.040.0x	0.05	0.050.0x
FCF Margin	17.8%+16.4pp	7.7%+10.5pp	-50.2%-0.3pp	44.5%+19.4pp	1.4%-23.4pp	-2.8%-20.7pp	-49.9%	25.1%+4.8pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
DuPont de Nemours, Inc. DD	FY2025	$6.8B	$88.0M	1.3%	$17.6B	38/100
PPG Industries, Inc. PPG	FY2025	$15.9B	$1.6B	9.9%	$23.4B	58/100
Air Products & Chemicals, Inc. APD	FY2025	$12.0B	-$394.5M	-3.3%	$61.8B	33/100
LyondellBasell Industries N.V. LYB	FY2025	$30.2B	-$738.0M	-2.5%	$18.9B	33/100
International Flavors & Fragrances Inc. IFF	FY2025	$10.9B	-$359.0M	-3.3%	$21.0B	27/100
RPM International, Inc. RPM	FY2026	$7.9B	$662.0M	8.4%	$12.7B	35/100

Where DuPont de Nemours, Inc. Ranks

Frequently Asked Questions

What is DuPont de Nemours, Inc.'s annual revenue?

DuPont de Nemours, Inc. (DD) reported $6.8B in total revenue for fiscal year 2025. This represents a 1.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is DuPont de Nemours, Inc.'s revenue growing?

DuPont de Nemours, Inc. (DD) revenue grew by 1.9% year-over-year, from $6.7B to $6.8B in fiscal year 2025.

Is DuPont de Nemours, Inc. profitable?

Yes, DuPont de Nemours, Inc. (DD) reported a net income of $88.0M in fiscal year 2025, with a net profit margin of 1.3%.

How much debt does DuPont de Nemours, Inc. have?

As of fiscal year 2025, DuPont de Nemours, Inc. (DD) had $715.0M in cash and equivalents against $3.1B in long-term debt.

What is DuPont de Nemours, Inc.'s gross margin?

DuPont de Nemours, Inc. (DD) had a gross margin of 34.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is DuPont de Nemours, Inc.'s net profit margin?

DuPont de Nemours, Inc. (DD) had a net profit margin of 1.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does DuPont de Nemours, Inc. pay dividends?

Yes, DuPont de Nemours, Inc. (DD) paid $1.43 per share in dividends during fiscal year 2025.

What is DuPont de Nemours, Inc.'s return on equity (ROE)?

DuPont de Nemours, Inc. (DD) has a return on equity of 0.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is DuPont de Nemours, Inc.'s free cash flow?

DuPont de Nemours, Inc. (DD) generated $227.0M in free cash flow during fiscal year 2025. This represents a -52.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is DuPont de Nemours, Inc.'s operating cash flow?

DuPont de Nemours, Inc. (DD) generated $560.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are DuPont de Nemours, Inc.'s total assets?

DuPont de Nemours, Inc. (DD) had $21.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are DuPont de Nemours, Inc.'s capital expenditures?

DuPont de Nemours, Inc. (DD) invested $333.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does DuPont de Nemours, Inc. spend on research and development?

DuPont de Nemours, Inc. (DD) invested $193.0M in research and development during fiscal year 2025.

How many shares does DuPont de Nemours, Inc. have outstanding?

DuPont de Nemours, Inc. (DD) had 409M shares outstanding as of fiscal year 2025.

What is DuPont de Nemours, Inc.'s current ratio?

DuPont de Nemours, Inc. (DD) had a current ratio of 2.42 as of fiscal year 2025, which is generally considered healthy.

What is DuPont de Nemours, Inc.'s debt-to-equity ratio?

DuPont de Nemours, Inc. (DD) had a debt-to-equity ratio of 0.23 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is DuPont de Nemours, Inc.'s return on assets (ROA)?

DuPont de Nemours, Inc. (DD) had a return on assets of 0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is DuPont de Nemours, Inc.'s P/E ratio?

DuPont de Nemours, Inc. (DD) trades at 321x earnings, its market capitalization divided by net income of $55.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $17.6B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is DuPont de Nemours, Inc.'s price-to-sales ratio?

DuPont de Nemours, Inc. (DD) trades at 2.5x sales, its market capitalization divided by revenue of $7.0B revenue, trailing 12 months to June 30, 2026. The market capitalization is $17.6B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is DuPont de Nemours, Inc.'s Piotroski F-Score?

DuPont de Nemours, Inc. (DD) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are DuPont de Nemours, Inc.'s earnings high quality?

DuPont de Nemours, Inc. (DD) has an earnings quality ratio of 6.36x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is DuPont de Nemours, Inc.?

DuPont de Nemours, Inc. (DD) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.